Liposomal forms of new antitumor drugs based on europium chelates examined by p-terphenyl fluorescence quenching
Abstract
Europium chelates have been previously shown to possess pronounced cytotoxic activity. These
compounds are of great interest for biomedical investigations and diagnostics, because their spectral
characteristics are optimal for visualization of the occurred processes. Application of these pharmaceutical compounds in the free form is limited by their high toxicity and metabolic instability. In view of this, the development of the delivery systems for europium chelates becomes actual. Liposomes represent one of the most promising delivery systems, which allows to increase the efficiency of pharmacological agents. The use of liposomal formulations of antitumor drugs is currently in a focus of biomedical and biophysical research due to the following advantages: complete biocompatibility, ability to carry both lipophilic and hydrophilic compounds, protecting them from chemical degradation and transformation, decreased toxicity and increased therapeutic index of drug, etc. In the present work we explore the interaction between europium chelates (here referred to as V6 and V8) and model lipid membranes. Fluorescence intensity of membrane-incorporated probe p-terphenyl was found to decrease with enhancement of drugs concentration. The obtained results indicate that p-terphenyl fluorescence is quenched upon europium chelate incorporation into phosphatidylcholine liposomes. Quantitative characteristics of p-terphenyl fluorescence quenching by the drugs under consideration have been determined.
Downloads
References
2. Rowat A., Keller D., Ipsen J. Effects of farnesol on the physical properties of DMPC membranes // Biochim. Biophys. Acta. 2005. V. 1713. P. 29-39.
3. Torchilin V.P. Recent advances with liposomes as pharmaceutical carriers // Nat. Rev. Drug Discovery. 2005. V. 4. P. 145-160.
4. Yudintsev A., Trusova V., Gorbenko G., Deligeorgiev T., Vasilev A., Gadjev N. Lipid bilayer interactions of Eu(III) tris-b-diketonato coordination complex // Chem. Phys. Lett. 2008. V. 457. P. 417-420.
5. Momekov G., Deligeorgiev T., Vasilev A., Peneva K., Konstantinov S., Karaivanova M. Evaluation of the cytotoxic and pro-apoptotic activities of Eu(III) complexes with appended DNA intercalators in a panel of human malignant cell lines // Med. Chem. 2006. V. 2. P. 439-445.
6. Mui B., Chow L., Hope M.J. Extrusion technique to generate liposomes of defined size // Meth. Enzymol. 2003. V. 367. P. 3-14.
7. Lakowicz J.R. Principles of Fluorescent Spectroscopy, third ed. Plenum Press, New York. 2006.
8. Lucio M., Ferreira H., Lima F., Jose L., Reis S. Interactions between oxicams and membrane bilayers: an explanation for their different COX selectivity // Med. Chem. 2006. V. 2(5). P. 447-456.
9. Santos N., Prieto M., Castanho M. Quantifying molecular partition into model systems of biomembranes: an emphasis on optical spectroscopic methods // Biochim. Biophys. Acta. 2003. V. 1612. P. 123-135.
10. Lakowicz J., Hogen D., Omann G. Diffusion and partitioning of a pesticide, lindane, into phosphatidylcholine bilayers: a new fluorescence quenching method to study chlorinated hydrocarbo membrane interactions // Biochim. Biophys. Acta. 1977. V. 471. P. 401–411.
11. Meshkova S.B. The dependence of the luminescence intensity of lanthanide complexes with β-diketones on the ligand form // J. Fluoresc. 2000. V. 10(4). P. 333-337.
12. Ferreira H., Lucio M., Castro B., Gameiro P., Lima F., Reis S. Partition and location of nimesulide in EPC liposomes: a spectrophotometric and fluorescence study // Anal. Bioanal. Chem. 2003. V. 377. P. 293-298.
13. Gudasi K., Vidyadhar C., Havanur C., Patil S. Antimicrobial study of newly synthesized lanthanide(III) complexes of 2-[2-hydroxy-3-methoxyphenyl]-3-[2-hydroxy-3-methoxybenzylamino]-1,2-dihydroquinazolin-4(3H)-one // Met.-Based Drugs 2007. V. 2007. P. 1-7.
14. Zhang X., Lei X., Dai H. Synthesis and characterization of light lanthanide complexes with 5-aminosalicylic acid // Synth. React. Inorg. Met.-Org. Chem. 2004. V. 34(6). P. 1123-1134.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
